2020
DOI: 10.3390/molecules25245966
|View full text |Cite
|
Sign up to set email alerts
|

Cyclic RGD and isoDGR Integrin Ligands Containing cis-2-amino-1-cyclopentanecarboxylic (cis-β-ACPC) Scaffolds

Abstract: Integrin ligands containing the tripeptide sequences Arg-Gly-Asp (RGD) and iso-Asp-Gly- Arg (isoDGR) were actively investigated as inhibitors of tumor angiogenesis and directing unit in tumor-targeting drug conjugates. Reported herein is the synthesis, of two RGD and one isoDGR cyclic peptidomimetics containing (1S,2R) and (1R,2S) cis-2-amino-1-cyclopentanecarboxylic acid (cis-β-ACPC), using a mixed solid phase/solution phase synthetic protocol. The three ligands were examined in vitro in competitive binding a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 58 publications
0
2
0
Order By: Relevance
“…This would suggest that the dual inhibition of these RGD integrins can be a promising strategy to develop brand-new anti-HSV therapeutic agents. Nonetheless, while many ligands are available for αIIbβ3, αvβ3, and α5β1, few selective binders are known for αvβ6 and αvβ8. In this regard, we recently identified a cyclic pentapeptide, namely, [RGD-Chg-E]-CONH 2 ( 1 ) (Chart ), as a potent and preferential αvβ6 ligand, which was successfully converted into an effective probe for molecular imaging . Considering that herpesviruses employ both αvβ6 and αvβ8 as co-receptors for cellular entry, a dual ligand of these integrins should represent a more efficient anti-HSV agent than the corresponding mono-αvβ6- or αvβ8-selective binders.…”
Section: Introductionmentioning
confidence: 99%
“…This would suggest that the dual inhibition of these RGD integrins can be a promising strategy to develop brand-new anti-HSV therapeutic agents. Nonetheless, while many ligands are available for αIIbβ3, αvβ3, and α5β1, few selective binders are known for αvβ6 and αvβ8. In this regard, we recently identified a cyclic pentapeptide, namely, [RGD-Chg-E]-CONH 2 ( 1 ) (Chart ), as a potent and preferential αvβ6 ligand, which was successfully converted into an effective probe for molecular imaging . Considering that herpesviruses employ both αvβ6 and αvβ8 as co-receptors for cellular entry, a dual ligand of these integrins should represent a more efficient anti-HSV agent than the corresponding mono-αvβ6- or αvβ8-selective binders.…”
Section: Introductionmentioning
confidence: 99%
“…The unraveling of the bioactive conformation of cilengitide bound to integrin αVβ3 [222] and the rationalization of the biological affinity provided by Kessler's studies inspired and guided rational designs of several peptidomimetic ligands [222][223][224][225], including some integrin inhibitors which entered to clinical phases [221]. In the pioneering work of Mas-Moruno et al [226], a systematic stepwise strategy was developed to design cyclic peptides under "conformational control".…”
Section: Cyclizationmentioning
confidence: 99%
“…The unraveling of the bioactive conformation of cilengitide bound to integrin αVβ3 [222] and the rationalization of the biological affinity provided by Kessler's studies inspired and guided rational designs of several peptidomimetic ligands [222][223][224][225], including some integrin inhibitors which entered to clinical phases [221]. In the pioneering work of Mas-Moruno et al [226], a systematic stepwise strategy was developed to design cyclic peptides under "conformational control".…”
Section: Cyclizationmentioning
confidence: 99%